David Schenkein

General Partner at Google Ventures

David Schenkein

David Schenkein

General Partner at Google Ventures

Overview

Career Highlights

Agios Pharmaceuticals, Inc.

RelSci Relationships

7114

Number of Boards

12

Birthday

1958

Age

63

Contact Data

Trying to get in touch with David Schenkein? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!

Relationships

View Relationship Details

RelSci Relationships are individuals David Schenkein likely has professional access to. A relationship does not necessarily indicate a personal connection.

Lewis C. Cantley

Co-Founder at Agios Pharmaceuticals, Inc.

Relationship likelihood: Strong

John Maraganore

Chief Executive Officer at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Nick Leschly

Senior Professional at bluebird bio, Inc.

Relationship likelihood: Strong

Jacqualyn A. Fouse

Chief Executive Officer at Agios Pharmaceuticals, Inc.

Relationship likelihood: Strong

Marc Tessier-Lavigne

President at Stanford University

Relationship likelihood: Strong

Ryan J. Watts

Co-Founder at Denali Therapeutics, Inc.

Relationship likelihood: Strong

Xiaodong Wang

Co-Founder at BeiGene Ltd.

Relationship likelihood: Strong

Alexis Borisy

Co-Founder at EQRx, Inc.

Relationship likelihood: Strong

Ian Clark

Operating Partner at Clarus Ventures LLC

Relationship likelihood: Strong

Robert Nelsen

Co-Founder at Vir Biotechnology, Inc.

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.

In The News

RelSci

January 11, 2021

David Schenkein is no longer serving in their board position at bluebird bio, Inc.

Business Wire

January 11, 2021

bluebird bio to Separate Oncology Business into Independent Company; Severe Genetic Disease business will remain the focus of bluebird bio, Inc.; separation expected to result in two independent, publicly traded companies by year-end 2021; Separation desi

RelSci

January 8, 2021

David Schenkein sold $2.7M worth of shares in Denali Therapeutics, Inc. in December 2020

The Boston Globe

December 22, 2020

Agios will sell oncology business; The seller aims to focus on new therapies for genetic diseases

RelSci

December 8, 2020

David Schenkein sold $3.2M worth of shares in Denali Therapeutics, Inc. in November 2020

Paths to David Schenkein

Potential Connections via
Relationship Science

You

David Schenkein

General Partner at Google Ventures

Education

B.A., Chemistry

Wesleyan University

Wesleyan University is known for the excellence of its academic and co-curricular programs. About 2,900 undergraduates—and some 200 graduate students—from around the world pursue their classroom studies, research projects, and co-curricular interests in ways that are demanding and intensely rewarding. Here, on a beautiful campus overlooking the Connecticut River, students learn to do productive and innovative work that makes a positive difference in the world—that’s what Wesleyan is about.

MD

State University of New York Upstate Medical University

SUNY Upstate Medical University in Syracuse, NY, is the only academic medical center in Central New York. It is also the region's largest employer with 9,460 employees. Affiliated with the State University of New York, Upstate's mission is to improve the health of the community through education, biomedical research and health care. Upstate Medical University's educational mission is anchored by its four colleges—Medicine, Nursing, Health Professions and Graduate Studies (biomedical sciences). Since 2006, student enrollment has grown by 30% as Upstate responds to the needs of the region.

Career History

General Partner

2019 - Current

Google Ventures

Google Ventures invests in a broad range of industries including consumer Internet, software, hardware, clean technology, biotechnology and healthcare. Their investments range from seed to mezzanine stage. The firm looks for entrepreneurs who are solving problems in innovative ways that have the potential for significant financial return.

President, Chief Executive Officer & Director

2009 - Prior

Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Senior Vice President-Oncology Development

2006 - 2009

Genentech, Inc.

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer, Kenneth B. Lee and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Boards & Committees

Member, Scientific Advisory Board

Current

BeiGene (Beijing) Co., Ltd.

BeiGene (Beijing) Co., Ltd., part of BeiGene Ltd., is a company headquartered in Beijing, China, that develops pharmaceuticals.

Board Member

Current

Cavu(CAVU Foundation Inc)

Member, Emerging Companies Section Governing Board

2012 - 2015

Biotechnology Innovation Organization

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Board Member

Tenure Unconfirmed

Tuberous Sclerosis Alliance

FINDING A CURE FOR TUBEROUS SCLEROSIS COMPLEX WHILE IMPROVING THE LIVES OF THOSE AFFECTED.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci

$250 - $499

2006

Tufts Medical Center, Inc.

Tufts Medical Center, Inc. owns and operates an academic medical center. It provides healthcare services and programs in the areas of allergy, anesthesiology, bariatric surgery, cancer, cardiology, colon and rectal, clinical nutrition, dentistry, dermatology, ENT/otolaryngology, endocrinology, diabetes and metabolism, gastroenterology, general surgery, geriatrics, hematology/oncology, hyperbaric medicine, infectious diseases, maternity, nephrology, neurology, neurosurgery, and nutrition. The firm also offers services in the areas of obstetrics and gynecology, occupational therapy, ophthalmology, orthopedics, otolaryngology, pain management, palliative care, pathology, pediatrics, physical medicine, physical therapy, plastic surgery, psychiatry, pulmonary, radiation oncology, radiology, rheumatology, speech language pathology and audiology, thoracic and transplant surgery, trauma surgery, urology, vascular surgery, wound healing, and weight and wellness. The company was founded in 1796 and is headquartered in Boston, MA.

Political Donations

$250

2011

Daniel Wolf

Former Director at CCBT Financial Cos., Inc.

$250

2010

Daniel Wolf

Former Director at CCBT Financial Cos., Inc.

$250

2004

John Kerry

Former Senator from Massachusetts

Transactions

Details Hidden

Agios Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Agios Pharmaceuticals, Inc. raised money in a private placement transaction

Investments

Details Hidden

Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Public Holdings

Restricted data only for RelSci Professional users.

Other Affiliations

David Schenkein is affiliated with Google Ventures, Agios Pharmaceuticals, Inc., Genentech, Inc., Takeda Oncology Co., ARCH Venture Partners, Tufts Medical Center, Inc., Stanford University - School of Medicine, BeiGene (Beijing) Co., Ltd., Cavu(CAVU Foundation Inc), Biotechnology Innovation Organization, Tuberous Sclerosis Alliance

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by David Schenkein. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of David Schenkein's profile does not indicate a business or promotional relationship of any kind between RelSci and David Schenkein.